![](https://webarchive.library.unt.edu/eot2008/20081107190942im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081107190942im_/http://www.cancer.gov/images/spacer.gif)
| A substance that is being studied in the treatment of cancer. It is made by combining the monoclonal antibody CC49 with a chemical called streptavidin. It can find tumor cells that have the protein TAG-72 on their surface, including colon, prostate, breast, and ovary cancer cells. After CC49-streptavidin binds to cancer cells, a radioactive compound called yttrium Y 90 DOTA-biotin will find those cells and kill them. |
Previous Definitions: | CC-1088, CC-4047, CC-49, CC-5013, CC-8490 | Next Definitions: | CCI-779, cCLB8, CD134, CD34 antigen, CD40-ligand |
|
![](https://webarchive.library.unt.edu/eot2008/20081107190942im_/http://www.cancer.gov/images/spacer.gif) |